CLINICAL_TRIALS
withdrawal
· 2013-02-20
Clinical Trial Update: Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [Phase 2]
Summary
A Phase 2 trial of ceftobiprole for hospitalized patients with Staphylococcus aureus bacteremia was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Basilea Pharmaceutica | Conditions: Bacteremia | Phase 2 | Status: WITHDRAWN